266 related articles for article (PubMed ID: 17418405)
1. Fumarate hydratase deficiency and cancer: activation of hypoxia signaling?
Ratcliffe PJ
Cancer Cell; 2007 Apr; 11(4):303-5. PubMed ID: 17418405
[TBL] [Abstract][Full Text] [Related]
2. Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis.
Smit DL; Mensenkamp AR; Badeloe S; Breuning MH; Simon ME; van Spaendonck KY; Aalfs CM; Post JG; Shanley S; Krapels IP; Hoefsloot LH; van Moorselaar RJ; Starink TM; Bayley JP; Frank J; van Steensel MA; Menko FH
Clin Genet; 2011 Jan; 79(1):49-59. PubMed ID: 20618355
[TBL] [Abstract][Full Text] [Related]
3. [Hereditary leiomyomatosis and renal cell cancer - HLRCC/multiple cutaneous and uterine leimomyomatosis - MCUL].
Plevová P; Hladíková A; Tesařová M
Klin Onkol; 2012; 25 Suppl():S55-8. PubMed ID: 22920208
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a founder effect of the germline fumarate hydratase gene mutation R58P causing hereditary leiomyomatosis and renal cell cancer (HLRCC).
Heinritz W; Paasch U; Sticherling M; Wittekind C; Simon JC; Froster UG; Renner R
Ann Hum Genet; 2008 Jan; 72(Pt 1):35-40. PubMed ID: 17908262
[TBL] [Abstract][Full Text] [Related]
5. Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway.
Pollard PJ; Spencer-Dene B; Shukla D; Howarth K; Nye E; El-Bahrawy M; Deheragoda M; Joannou M; McDonald S; Martin A; Igarashi P; Varsani-Brown S; Rosewell I; Poulsom R; Maxwell P; Stamp GW; Tomlinson IP
Cancer Cell; 2007 Apr; 11(4):311-9. PubMed ID: 17418408
[TBL] [Abstract][Full Text] [Related]
6. Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability.
Lehtonen HJ; Mäkinen MJ; Kiuru M; Laiho P; Herva R; van Minderhout I; Hogendoorn PC; Cornelisse C; Devilee P; Launonen V; Aaltonen LA
Int J Cancer; 2007 Sep; 121(6):1386-9. PubMed ID: 17520677
[TBL] [Abstract][Full Text] [Related]
7. HIF and fumarate hydratase in renal cancer.
Sudarshan S; Linehan WM; Neckers L
Br J Cancer; 2007 Feb; 96(3):403-7. PubMed ID: 17211469
[TBL] [Abstract][Full Text] [Related]
8. Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma.
Ylisaukko-oja SK; Cybulski C; Lehtonen R; Kiuru M; Matyjasik J; Szymañska A; Szymañska-Pasternak J; Dyrskjot L; Butzow R; Orntoft TF; Launonen V; Lubiñski J; Aaltonen LA
Eur J Hum Genet; 2006 Jul; 14(7):880-3. PubMed ID: 16639410
[TBL] [Abstract][Full Text] [Related]
9. Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis.
Badeloe S; Frank J
Eur J Dermatol; 2009; 19(6):545-51. PubMed ID: 19939761
[TBL] [Abstract][Full Text] [Related]
10. Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status.
Bardella C; El-Bahrawy M; Frizzell N; Adam J; Ternette N; Hatipoglu E; Howarth K; O'Flaherty L; Roberts I; Turner G; Taylor J; Giaslakiotis K; Macaulay VM; Harris AL; Chandra A; Lehtonen HJ; Launonen V; Aaltonen LA; Pugh CW; Mihai R; Trudgian D; Kessler B; Baynes JW; Ratcliffe PJ; Tomlinson IP; Pollard PJ
J Pathol; 2011 Sep; 225(1):4-11. PubMed ID: 21630274
[TBL] [Abstract][Full Text] [Related]
11. Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer.
Ahvenainen T; Lehtonen HJ; Lehtonen R; Vahteristo P; Aittomäki K; Baynam G; Dommering C; Eng C; Gruber SB; Grönberg H; Harvima R; Herva R; Hietala M; Kujala M; Kääriäinen H; Sunde L; Vierimaa O; Pollard PJ; Tomlinson IP; Björck E; Aaltonen LA; Launonen V
Cancer Genet Cytogenet; 2008 Jun; 183(2):83-8. PubMed ID: 18503824
[TBL] [Abstract][Full Text] [Related]
12. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome.
Merino MJ; Torres-Cabala C; Pinto P; Linehan WM
Am J Surg Pathol; 2007 Oct; 31(10):1578-85. PubMed ID: 17895761
[TBL] [Abstract][Full Text] [Related]
13. A novel missense mutation in fumarate hydratase in an Italian patient with a diffuse variant of cutaneous leiomyomatosis (Reed's syndrome).
Rongioletti F; Fausti V; Ferrando B; Parodi A; Mandich P; Pasini B
Dermatology; 2010; 221(4):378-80. PubMed ID: 21051878
[TBL] [Abstract][Full Text] [Related]
14. [From gene to disease; cutaneous leiomyomatosis].
Badeloe S; van Geel M; van Steensel MA; Steijlen PM; Poblete-Gutiérrez P; Frank JA
Ned Tijdschr Geneeskd; 2007 Feb; 151(5):300-4. PubMed ID: 17326474
[TBL] [Abstract][Full Text] [Related]
15. The syndrome of hereditary leiomyomatosis and renal cell cancer (HLRCC): The clinical features of an individual with a fumarate hydratase gene mutation.
Varol A; Stapleton K; Roscioli T
Australas J Dermatol; 2006 Nov; 47(4):274-6. PubMed ID: 17034471
[TBL] [Abstract][Full Text] [Related]
16. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer.
Alam NA; Olpin S; Leigh IM
Br J Dermatol; 2005 Jul; 153(1):11-7. PubMed ID: 16029320
[TBL] [Abstract][Full Text] [Related]
17. A role for mitochondrial enzymes in inherited neoplasia and beyond.
Eng C; Kiuru M; Fernandez MJ; Aaltonen LA
Nat Rev Cancer; 2003 Mar; 3(3):193-202. PubMed ID: 12612654
[TBL] [Abstract][Full Text] [Related]
18. Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research.
Ooi A
Semin Cancer Biol; 2020 Apr; 61():158-166. PubMed ID: 31689495
[TBL] [Abstract][Full Text] [Related]
19. Prospective Detection of Germline Mutation of Fumarate Hydratase in Women With Uterine Smooth Muscle Tumors Using Pathology-based Screening to Trigger Genetic Counseling for Hereditary Leiomyomatosis Renal Cell Carcinoma Syndrome: A 5-Year Single Institutional Experience.
Rabban JT; Chan E; Mak J; Zaloudek C; Garg K
Am J Surg Pathol; 2019 May; 43(5):639-655. PubMed ID: 30741757
[TBL] [Abstract][Full Text] [Related]
20. Cells lacking the fumarase tumor suppressor are protected from apoptosis through a hypoxia-inducible factor-independent, AMPK-dependent mechanism.
Bardella C; Olivero M; Lorenzato A; Geuna M; Adam J; O'Flaherty L; Rustin P; Tomlinson I; Pollard PJ; Di Renzo MF
Mol Cell Biol; 2012 Aug; 32(15):3081-94. PubMed ID: 22645311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
